EU Clinical Trial Information System (CTIS)

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes

LUNAR IIIb study comparing rosuvastatin and atorvastatin in subjects with acute coronary syndromes

Research Site

A 12-week randomized, open-label 3-arm, parallel group, multicenter Phase IIIb study comparing efficacy and safety of rosuvastatin 20mg and 40mg with that of atorvastatin 80 mg in subjects with acute coronary syndromes

LUNAR IIIb study comparing rosuvastatin and atorvastatin in subjects with acute coronary syndromes

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1576&filename=CSR-D3560L00021.pdf

CSR-D3560L00021.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator